Cleveland Biolabs, Inc. (CBLI) to present at the Robins Emerging Opportunities Investment Conference.

Cleveland Biolabs, Inc is a drug discovery and development company leveraging its proprietary discoveries about programmed cell death to treat cancer and protect normal tissues from exposure to radiation and other stresses. The Company has strategic partnerships with the Cleveland Clinic Foundation, Roswell Park Cancer Institute, ChemBridge Corporation and the Armed Forces Research Radiobiology Institute.

To Register, contact Aimee Boutcher (973) 239-2878, or register online:
Register Online